SnowBrand Treatment For Sjogren's Symptoms Evoxac Will Launch In Spring
Executive Summary
SnowBrand Pharmaceuticals anticipates a spring launch for Evoxac (cevimeline), approved Jan. 11 for treatment of dry mouth symptoms in patients with Sjogren's syndrome.